135 related articles for article (PubMed ID: 16847286)
1. Summaries for patients. Effects of drug treatment for obesity in adolescence.
Ann Intern Med; 2006 Jul; 145(2):I16. PubMed ID: 16847286
[No Abstract] [Full Text] [Related]
2. Effects of sibutramine treatment in obese adolescents: a randomized trial.
Berkowitz RI; Fujioka K; Daniels SR; Hoppin AG; Owen S; Perry AC; Sothern MS; Renz CL; Pirner MA; Walch JK; Jasinsky O; Hewkin AC; Blakesley VA;
Ann Intern Med; 2006 Jul; 145(2):81-90. PubMed ID: 16847290
[TBL] [Abstract][Full Text] [Related]
3. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.
Berkowitz RI; Wadden TA; Tershakovec AM; Cronquist JL
JAMA; 2003 Apr; 289(14):1805-12. PubMed ID: 12684359
[TBL] [Abstract][Full Text] [Related]
4. Does drug therapy of obesity have a future?
Trakas K; Leiter L; Shear NH
Can J Clin Pharmacol; 2000; 7(3):133-4. PubMed ID: 11044757
[No Abstract] [Full Text] [Related]
5. Diet drug helps keep weight off.
Health News; 2001 Feb; 7(2):6. PubMed ID: 11232119
[No Abstract] [Full Text] [Related]
6. What constitutes successful weight management in adolescents?
Dietz WH
Ann Intern Med; 2006 Jul; 145(2):145-6. PubMed ID: 16847296
[No Abstract] [Full Text] [Related]
7. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
8. Influence of weight reduction by sibutramine on female sexual function.
Kim KK; Kang HC; Kim SS; Youn BB
Int J Obes (Lond); 2006 May; 30(5):758-63. PubMed ID: 16404407
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological concepts for the treatment of obesity - a therapeutic meander?].
Schindler C; Chavakis T; Lamounier-Zepter V; Bornstein SR
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1570-3. PubMed ID: 21809243
[No Abstract] [Full Text] [Related]
10. Valuable lessons from research on drugs for adolescent obesity in Mexico.
Bastarrachea RA; López-Alvarenga J; Calzada-León R; Arellano-Montaño S; Gonzalez-Barranco J
Adv Ther; 2006; 23(3):506-7; author reply 507-9. PubMed ID: 16989042
[No Abstract] [Full Text] [Related]
11. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
Fanghänel G; Cortinas L; Sánchez-Reyes L; Berber A
Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
[TBL] [Abstract][Full Text] [Related]
12. European Medicines Agency withdrawal for sibutramine.
Galhardo J; Davis N; Matthai S; Shield JP
Arch Dis Child; 2010 Oct; 95(10):856. PubMed ID: 20573736
[No Abstract] [Full Text] [Related]
13. Sibutramine for obesity.
Med Lett Drugs Ther; 1998 Mar; 40(1022):32. PubMed ID: 9529518
[No Abstract] [Full Text] [Related]
14. Reduced left ventricular mass after treatment of obese patients with sibutramine: An echocardiographic multicentre study.
Wirth A; Scholze J; Sharma AM; Matiba B; Boenner G
Diabetes Obes Metab; 2006 Nov; 8(6):674-81. PubMed ID: 17026492
[TBL] [Abstract][Full Text] [Related]
15. Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.
Wooltorton E
CMAJ; 2002 May; 166(10):1307-8. PubMed ID: 12041851
[No Abstract] [Full Text] [Related]
16. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
17. Sibutramine: an Australian analysis of reported adverse effects.
Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590911
[No Abstract] [Full Text] [Related]
18. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
[TBL] [Abstract][Full Text] [Related]
19. [No progress without the physician in therapy of obesity].
Schmidt H; Plauth M
MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
